Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Nicotinic | 21 | 2016 | 494 | 1.840 |
Why?
|
Nicotinic Agonists | 13 | 2016 | 265 | 1.260 |
Why?
|
Behavior, Animal | 18 | 2022 | 1866 | 0.920 |
Why?
|
Motor Activity | 13 | 2019 | 2687 | 0.780 |
Why?
|
Antidepressive Agents | 12 | 2016 | 2890 | 0.730 |
Why?
|
Azetidines | 6 | 2014 | 141 | 0.700 |
Why?
|
Nicotine | 8 | 2008 | 677 | 0.530 |
Why?
|
Neurotransmitter Uptake Inhibitors | 2 | 2010 | 36 | 0.460 |
Why?
|
Amitriptyline | 2 | 2004 | 112 | 0.450 |
Why?
|
Rodentia | 1 | 2014 | 260 | 0.430 |
Why?
|
Fear | 11 | 2024 | 1462 | 0.400 |
Why?
|
Quinoxalines | 2 | 2011 | 297 | 0.400 |
Why?
|
Benzazepines | 2 | 2011 | 311 | 0.400 |
Why?
|
Antidepressive Agents, Tricyclic | 2 | 2004 | 432 | 0.390 |
Why?
|
Glycogen Synthase Kinase 3 | 2 | 2011 | 410 | 0.390 |
Why?
|
Gamma Rays | 2 | 2024 | 317 | 0.390 |
Why?
|
CLOCK Proteins | 1 | 2011 | 86 | 0.370 |
Why?
|
Iron Radioisotopes | 2 | 2021 | 19 | 0.370 |
Why?
|
Alzheimer Disease | 9 | 2024 | 8547 | 0.360 |
Why?
|
Helplessness, Learned | 4 | 2004 | 28 | 0.330 |
Why?
|
Cyclopropanes | 3 | 2017 | 431 | 0.320 |
Why?
|
Pyridines | 5 | 2011 | 2879 | 0.320 |
Why?
|
Sex Characteristics | 6 | 2024 | 2629 | 0.320 |
Why?
|
Mice, Inbred C57BL | 24 | 2024 | 22023 | 0.310 |
Why?
|
Alzheimer Vaccines | 2 | 2020 | 25 | 0.300 |
Why?
|
Locomotion | 1 | 2010 | 387 | 0.300 |
Why?
|
Presenilin-1 | 3 | 2021 | 660 | 0.290 |
Why?
|
Mice | 48 | 2024 | 81208 | 0.280 |
Why?
|
Hippocampus | 7 | 2023 | 3738 | 0.280 |
Why?
|
Swimming | 4 | 2011 | 207 | 0.280 |
Why?
|
Drug Discovery | 1 | 2014 | 1057 | 0.270 |
Why?
|
Antipsychotic Agents | 4 | 2017 | 3061 | 0.270 |
Why?
|
Animals | 67 | 2024 | 167963 | 0.260 |
Why?
|
Morphine | 4 | 2001 | 655 | 0.250 |
Why?
|
Mice, Knockout | 21 | 2024 | 14372 | 0.250 |
Why?
|
Anxiety | 4 | 2019 | 4538 | 0.240 |
Why?
|
Mice, Transgenic | 10 | 2024 | 9530 | 0.240 |
Why?
|
Cosmic Radiation | 1 | 2024 | 20 | 0.240 |
Why?
|
Complement C3 | 2 | 2017 | 451 | 0.240 |
Why?
|
Plaque, Amyloid | 3 | 2021 | 758 | 0.230 |
Why?
|
Disease Models, Animal | 10 | 2024 | 18137 | 0.230 |
Why?
|
Serotonin 5-HT2 Receptor Agonists | 2 | 2017 | 31 | 0.230 |
Why?
|
Hindlimb Suspension | 4 | 2010 | 75 | 0.220 |
Why?
|
Pyrrolidonecarboxylic Acid | 3 | 2021 | 65 | 0.220 |
Why?
|
Benzhydryl Compounds | 1 | 2010 | 941 | 0.220 |
Why?
|
Wakefulness | 1 | 2010 | 1255 | 0.210 |
Why?
|
Methylamines | 2 | 2017 | 138 | 0.210 |
Why?
|
Cocaine | 4 | 2010 | 961 | 0.200 |
Why?
|
Structure-Activity Relationship | 9 | 2017 | 3084 | 0.200 |
Why?
|
Central Nervous System Stimulants | 2 | 2010 | 1174 | 0.200 |
Why?
|
Islet Amyloid Polypeptide | 1 | 2021 | 42 | 0.200 |
Why?
|
Piperidines | 1 | 2010 | 1650 | 0.200 |
Why?
|
Amyloid beta-Peptides | 6 | 2024 | 3832 | 0.200 |
Why?
|
Conditioning, Classical | 5 | 2005 | 364 | 0.190 |
Why?
|
alpha-Synuclein | 2 | 2018 | 749 | 0.190 |
Why?
|
RGS Proteins | 2 | 2013 | 75 | 0.190 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2011 | 10827 | 0.180 |
Why?
|
Dementia, Vascular | 1 | 2021 | 123 | 0.180 |
Why?
|
Isoxazoles | 2 | 2012 | 230 | 0.170 |
Why?
|
Maze Learning | 5 | 2024 | 477 | 0.170 |
Why?
|
Mice, Inbred BALB C | 7 | 2019 | 6216 | 0.170 |
Why?
|
Socialization | 1 | 2019 | 86 | 0.170 |
Why?
|
Nicotinic Antagonists | 4 | 2014 | 94 | 0.170 |
Why?
|
Drug Partial Agonism | 4 | 2012 | 24 | 0.160 |
Why?
|
Brain | 12 | 2024 | 26951 | 0.160 |
Why?
|
Anti-Anxiety Agents | 1 | 2021 | 397 | 0.160 |
Why?
|
Ligands | 7 | 2017 | 3276 | 0.160 |
Why?
|
tau Proteins | 3 | 2021 | 2085 | 0.160 |
Why?
|
Brain Chemistry | 1 | 2002 | 959 | 0.160 |
Why?
|
Electroshock | 7 | 2005 | 121 | 0.150 |
Why?
|
Rats | 16 | 2021 | 23711 | 0.150 |
Why?
|
Rats, Sprague-Dawley | 11 | 2010 | 8158 | 0.150 |
Why?
|
Freezing Reaction, Cataleptic | 2 | 2016 | 41 | 0.150 |
Why?
|
Urination | 1 | 2019 | 202 | 0.150 |
Why?
|
Association Learning | 3 | 2006 | 219 | 0.150 |
Why?
|
Physical Conditioning, Animal | 1 | 2021 | 366 | 0.150 |
Why?
|
Fibronectins | 1 | 2021 | 722 | 0.150 |
Why?
|
Receptor, Serotonin, 5-HT2C | 1 | 2017 | 42 | 0.150 |
Why?
|
Larva | 2 | 2016 | 509 | 0.150 |
Why?
|
Receptors, GABA-A | 1 | 2022 | 621 | 0.150 |
Why?
|
Hormones | 1 | 2021 | 867 | 0.140 |
Why?
|
Reflex | 1 | 2019 | 376 | 0.140 |
Why?
|
Neurons | 7 | 2018 | 9426 | 0.140 |
Why?
|
Immunization, Passive | 2 | 2020 | 616 | 0.140 |
Why?
|
Dopamine Uptake Inhibitors | 2 | 2010 | 297 | 0.140 |
Why?
|
Seizures | 2 | 2022 | 2917 | 0.140 |
Why?
|
Memory | 3 | 2024 | 2179 | 0.140 |
Why?
|
Space Flight | 1 | 2019 | 214 | 0.140 |
Why?
|
Depression | 5 | 2014 | 8044 | 0.140 |
Why?
|
Bipolar Disorder | 2 | 2011 | 5078 | 0.140 |
Why?
|
Escape Reaction | 1 | 2016 | 57 | 0.130 |
Why?
|
Tobacco Use Disorder | 1 | 2002 | 700 | 0.130 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2017 | 213 | 0.130 |
Why?
|
Benzylamines | 1 | 2017 | 248 | 0.130 |
Why?
|
Receptors, sigma | 1 | 2016 | 45 | 0.130 |
Why?
|
Mecamylamine | 2 | 2006 | 27 | 0.130 |
Why?
|
Molecular Structure | 4 | 2016 | 1895 | 0.130 |
Why?
|
Amyloid beta-Protein Precursor | 2 | 2021 | 1110 | 0.130 |
Why?
|
Microglia | 2 | 2022 | 1351 | 0.130 |
Why?
|
Antibodies, Monoclonal | 3 | 2020 | 9185 | 0.130 |
Why?
|
Parkinsonian Disorders | 1 | 2018 | 284 | 0.130 |
Why?
|
Neurosciences | 1 | 2019 | 353 | 0.120 |
Why?
|
Synaptosomes | 2 | 2015 | 115 | 0.120 |
Why?
|
Cognition | 4 | 2021 | 6957 | 0.120 |
Why?
|
Apyrase | 1 | 2017 | 373 | 0.120 |
Why?
|
Stress, Physiological | 1 | 2002 | 1398 | 0.120 |
Why?
|
Zebrafish | 2 | 2016 | 2997 | 0.120 |
Why?
|
Stereoisomerism | 5 | 2017 | 617 | 0.120 |
Why?
|
Nerve Degeneration | 2 | 2017 | 748 | 0.120 |
Why?
|
Dopamine | 3 | 2010 | 1595 | 0.120 |
Why?
|
Neuroglia | 1 | 2020 | 944 | 0.110 |
Why?
|
Pain Threshold | 3 | 1996 | 603 | 0.110 |
Why?
|
Substance-Related Disorders | 2 | 2010 | 4371 | 0.110 |
Why?
|
Organ Transplantation | 1 | 2023 | 1150 | 0.110 |
Why?
|
Avoidance Learning | 4 | 2005 | 248 | 0.110 |
Why?
|
Social Behavior | 1 | 2019 | 1131 | 0.110 |
Why?
|
Analgesia | 1 | 1997 | 459 | 0.100 |
Why?
|
Aging | 5 | 2023 | 8651 | 0.100 |
Why?
|
Adenosine | 1 | 2017 | 834 | 0.100 |
Why?
|
Male | 39 | 2024 | 359744 | 0.100 |
Why?
|
Amygdala | 1 | 2019 | 1351 | 0.100 |
Why?
|
Analysis of Variance | 3 | 2008 | 6238 | 0.090 |
Why?
|
Heart | 1 | 2024 | 4393 | 0.090 |
Why?
|
Adenosine Triphosphate | 1 | 2017 | 1993 | 0.090 |
Why?
|
Mice, Inbred A | 1 | 2010 | 246 | 0.090 |
Why?
|
Aza Compounds | 1 | 2010 | 34 | 0.090 |
Why?
|
Radioligand Assay | 4 | 2012 | 366 | 0.090 |
Why?
|
Small Molecule Libraries | 1 | 2016 | 734 | 0.090 |
Why?
|
Mice, Mutant Strains | 2 | 2011 | 1753 | 0.090 |
Why?
|
Depressive Disorder | 1 | 2003 | 3726 | 0.090 |
Why?
|
Nociceptors | 1 | 1994 | 457 | 0.090 |
Why?
|
Biogenic Monoamines | 1 | 2010 | 50 | 0.090 |
Why?
|
Tranylcypromine | 1 | 2009 | 30 | 0.080 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2023 | 881 | 0.080 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2010 | 186 | 0.080 |
Why?
|
Chromosome Mapping | 1 | 1997 | 4625 | 0.080 |
Why?
|
Kidney | 1 | 2024 | 7064 | 0.080 |
Why?
|
Substance Withdrawal Syndrome | 3 | 2010 | 622 | 0.080 |
Why?
|
Cell Proliferation | 1 | 2004 | 10446 | 0.080 |
Why?
|
Time Factors | 5 | 2021 | 40165 | 0.080 |
Why?
|
GTP-Binding Proteins | 1 | 2013 | 951 | 0.080 |
Why?
|
Pyrrolidines | 1 | 2010 | 340 | 0.080 |
Why?
|
Transcription, Genetic | 2 | 2019 | 7593 | 0.080 |
Why?
|
Mitochondria | 1 | 2022 | 3600 | 0.080 |
Why?
|
Norepinephrine | 1 | 2010 | 900 | 0.070 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2010 | 415 | 0.070 |
Why?
|
Gene Expression Regulation | 2 | 2017 | 11903 | 0.070 |
Why?
|
Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2006 | 29 | 0.070 |
Why?
|
Genotype | 1 | 2021 | 12960 | 0.070 |
Why?
|
Aminopyridines | 1 | 2010 | 564 | 0.070 |
Why?
|
Cerebral Cortex | 3 | 2017 | 5761 | 0.070 |
Why?
|
Neuralgia | 1 | 2013 | 600 | 0.070 |
Why?
|
Protein Binding | 4 | 2012 | 9335 | 0.070 |
Why?
|
Nucleus Accumbens | 3 | 2006 | 365 | 0.070 |
Why?
|
Sex Factors | 4 | 2024 | 10547 | 0.070 |
Why?
|
Cognition Disorders | 2 | 2021 | 3976 | 0.060 |
Why?
|
Serotonin | 1 | 2010 | 1040 | 0.060 |
Why?
|
Random Allocation | 1 | 2010 | 2394 | 0.060 |
Why?
|
Hypothalamus | 1 | 2010 | 998 | 0.060 |
Why?
|
Nortriptyline | 1 | 2004 | 79 | 0.060 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2010 | 1347 | 0.060 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2006 | 483 | 0.060 |
Why?
|
Bromodeoxyuridine | 1 | 2004 | 311 | 0.060 |
Why?
|
Corpus Striatum | 1 | 2010 | 1233 | 0.060 |
Why?
|
Lithium | 1 | 2007 | 596 | 0.060 |
Why?
|
Recreation | 1 | 2004 | 120 | 0.060 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2005 | 232 | 0.060 |
Why?
|
Immunotherapy | 2 | 2021 | 4642 | 0.060 |
Why?
|
Mice, Inbred ICR | 2 | 2003 | 364 | 0.060 |
Why?
|
Antiparkinson Agents | 2 | 2018 | 183 | 0.060 |
Why?
|
Antimanic Agents | 1 | 2007 | 520 | 0.050 |
Why?
|
Parkinson Disease | 1 | 2017 | 2859 | 0.050 |
Why?
|
Models, Biological | 1 | 2019 | 9467 | 0.050 |
Why?
|
Binding, Competitive | 3 | 2011 | 1142 | 0.050 |
Why?
|
Asphyxia | 1 | 2003 | 60 | 0.050 |
Why?
|
Pain Measurement | 3 | 2003 | 3528 | 0.050 |
Why?
|
Neurons, Efferent | 1 | 2003 | 81 | 0.050 |
Why?
|
Neuronal Plasticity | 2 | 2015 | 1430 | 0.050 |
Why?
|
Area Postrema | 1 | 2021 | 6 | 0.050 |
Why?
|
Electrical Synapses | 1 | 2022 | 18 | 0.050 |
Why?
|
Drug Design | 1 | 2007 | 1061 | 0.050 |
Why?
|
Oncogene Protein v-akt | 1 | 2022 | 129 | 0.050 |
Why?
|
Hypertension | 1 | 2022 | 8594 | 0.050 |
Why?
|
Microsomes, Liver | 2 | 2012 | 173 | 0.050 |
Why?
|
Circadian Rhythm | 2 | 2011 | 2571 | 0.050 |
Why?
|
Obesity | 1 | 2024 | 12922 | 0.050 |
Why?
|
Arousal | 2 | 2000 | 1157 | 0.050 |
Why?
|
Gliosis | 2 | 2017 | 244 | 0.050 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2009 | 1245 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2696 | 0.050 |
Why?
|
Female | 21 | 2024 | 391270 | 0.050 |
Why?
|
Gambling | 1 | 2004 | 258 | 0.050 |
Why?
|
Neuropeptides | 1 | 2006 | 943 | 0.050 |
Why?
|
Nerve Tissue Proteins | 2 | 2005 | 4407 | 0.050 |
Why?
|
Synaptic Vesicles | 1 | 2002 | 190 | 0.050 |
Why?
|
Genetics, Behavioral | 1 | 2000 | 53 | 0.050 |
Why?
|
Cell Count | 1 | 2004 | 1835 | 0.040 |
Why?
|
Hybridization, Genetic | 1 | 2000 | 103 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2008 | 4899 | 0.040 |
Why?
|
Cytoskeleton | 1 | 2005 | 1167 | 0.040 |
Why?
|
Drug Interactions | 1 | 2004 | 1428 | 0.040 |
Why?
|
Prefrontal Cortex | 1 | 2010 | 2212 | 0.040 |
Why?
|
Habituation, Psychophysiologic | 1 | 2000 | 147 | 0.040 |
Why?
|
Carbon Dioxide | 1 | 2003 | 1146 | 0.040 |
Why?
|
Conditioning, Operant | 1 | 2000 | 308 | 0.040 |
Why?
|
Mice, Inbred DBA | 1 | 2019 | 622 | 0.040 |
Why?
|
Mice, Inbred Strains | 2 | 2000 | 1763 | 0.040 |
Why?
|
Exploratory Behavior | 2 | 2015 | 273 | 0.040 |
Why?
|
Neurotransmitter Agents | 1 | 2002 | 663 | 0.040 |
Why?
|
Adrenergic beta-1 Receptor Agonists | 1 | 2017 | 14 | 0.040 |
Why?
|
Receptor, Serotonin, 5-HT2B | 1 | 2017 | 6 | 0.040 |
Why?
|
Levodopa | 1 | 2018 | 217 | 0.040 |
Why?
|
Cocaine-Related Disorders | 1 | 2001 | 460 | 0.040 |
Why?
|
Memory Disorders | 1 | 2005 | 1197 | 0.040 |
Why?
|
Endocytosis | 1 | 2002 | 959 | 0.040 |
Why?
|
Urinary Bladder, Overactive | 1 | 2019 | 114 | 0.040 |
Why?
|
Protons | 1 | 2023 | 1114 | 0.040 |
Why?
|
Self Administration | 2 | 2010 | 390 | 0.040 |
Why?
|
Actins | 1 | 2005 | 2049 | 0.040 |
Why?
|
Hyperkinesis | 1 | 2017 | 89 | 0.040 |
Why?
|
Behavior | 1 | 2000 | 540 | 0.040 |
Why?
|
Lod Score | 1 | 1997 | 602 | 0.040 |
Why?
|
Signal Transduction | 5 | 2022 | 23376 | 0.040 |
Why?
|
Synapses | 2 | 2017 | 1757 | 0.030 |
Why?
|
Thalamus | 1 | 2003 | 1041 | 0.030 |
Why?
|
Humans | 22 | 2023 | 760621 | 0.030 |
Why?
|
Albuterol | 1 | 2017 | 212 | 0.030 |
Why?
|
Mice, Inbred C3H | 1 | 1997 | 915 | 0.030 |
Why?
|
Molecular Biology | 1 | 2000 | 580 | 0.030 |
Why?
|
Blood Proteins | 2 | 2012 | 1173 | 0.030 |
Why?
|
Norway | 1 | 2017 | 496 | 0.030 |
Why?
|
Protein Conformation | 2 | 2018 | 3969 | 0.030 |
Why?
|
Phagocytosis | 1 | 2022 | 1535 | 0.030 |
Why?
|
Propranolol | 1 | 2017 | 489 | 0.030 |
Why?
|
Synapsins | 1 | 2015 | 43 | 0.030 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2022 | 1132 | 0.030 |
Why?
|
Substantia Nigra | 1 | 2017 | 350 | 0.030 |
Why?
|
Synaptophysin | 1 | 2015 | 139 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2006 | 3707 | 0.030 |
Why?
|
Morphine Dependence | 1 | 1995 | 26 | 0.030 |
Why?
|
Dyspnea | 1 | 2003 | 1352 | 0.030 |
Why?
|
HEK293 Cells | 2 | 2017 | 4264 | 0.030 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2015 | 127 | 0.030 |
Why?
|
Solubility | 1 | 2017 | 1088 | 0.030 |
Why?
|
Immobilization | 1 | 1996 | 230 | 0.030 |
Why?
|
Neurogenesis | 1 | 2022 | 856 | 0.030 |
Why?
|
Drosophila Proteins | 1 | 2004 | 1699 | 0.030 |
Why?
|
Administration, Oral | 1 | 2003 | 4035 | 0.030 |
Why?
|
Eating | 1 | 2021 | 1539 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2022 | 1791 | 0.030 |
Why?
|
Reaction Time | 3 | 2001 | 2075 | 0.030 |
Why?
|
Quinolizines | 1 | 2014 | 21 | 0.030 |
Why?
|
Acetylation | 1 | 2017 | 1062 | 0.030 |
Why?
|
Azocines | 1 | 2014 | 21 | 0.030 |
Why?
|
Chromosomes | 1 | 1997 | 575 | 0.030 |
Why?
|
Quantitative Trait, Heritable | 1 | 1997 | 540 | 0.030 |
Why?
|
Phenotype | 3 | 2021 | 16546 | 0.030 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2015 | 369 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2024 | 2802 | 0.030 |
Why?
|
Gene Deletion | 1 | 2021 | 2668 | 0.030 |
Why?
|
Learning | 2 | 2019 | 1739 | 0.030 |
Why?
|
Anilides | 1 | 2016 | 409 | 0.030 |
Why?
|
Alkaloids | 1 | 2014 | 194 | 0.030 |
Why?
|
Desipramine | 1 | 2013 | 182 | 0.030 |
Why?
|
Carbon Monoxide | 1 | 1996 | 540 | 0.030 |
Why?
|
Urinary Bladder | 1 | 2019 | 1166 | 0.030 |
Why?
|
Calcium-Binding Proteins | 1 | 2017 | 1067 | 0.030 |
Why?
|
Temperature | 1 | 2019 | 2221 | 0.030 |
Why?
|
Cell Line | 3 | 2012 | 15620 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2017 | 1135 | 0.020 |
Why?
|
Ether-A-Go-Go Potassium Channels | 1 | 2012 | 72 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2020 | 1974 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2017 | 1259 | 0.020 |
Why?
|
Receptors, Neurotransmitter | 1 | 2011 | 174 | 0.020 |
Why?
|
Protein Isoforms | 2 | 2009 | 1697 | 0.020 |
Why?
|
Neural Pathways | 1 | 2002 | 3040 | 0.020 |
Why?
|
Genetic Markers | 1 | 1997 | 2608 | 0.020 |
Why?
|
Health Status | 1 | 2004 | 4081 | 0.020 |
Why?
|
Mutation | 3 | 2024 | 29932 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2004 | 11071 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2017 | 1356 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2017 | 961 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2022 | 2869 | 0.020 |
Why?
|
Molecular Conformation | 1 | 2012 | 548 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2016 | 944 | 0.020 |
Why?
|
Light | 1 | 2016 | 1344 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7233 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2017 | 2209 | 0.020 |
Why?
|
Astrocytes | 1 | 2017 | 1338 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2018 | 2566 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2022 | 3539 | 0.020 |
Why?
|
Monoamine Oxidase Inhibitors | 1 | 2009 | 155 | 0.020 |
Why?
|
Discrimination Learning | 1 | 2010 | 278 | 0.020 |
Why?
|
Cricetulus | 1 | 2010 | 815 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2015 | 1296 | 0.020 |
Why?
|
Prosencephalon | 1 | 2010 | 305 | 0.020 |
Why?
|
Age Factors | 3 | 2015 | 18416 | 0.020 |
Why?
|
Gene Expression | 1 | 2021 | 7588 | 0.020 |
Why?
|
Treatment Failure | 1 | 2014 | 2648 | 0.020 |
Why?
|
Dyskinesia, Drug-Induced | 1 | 2009 | 165 | 0.020 |
Why?
|
Receptors, Opioid, mu | 1 | 2009 | 166 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2020 | 4541 | 0.020 |
Why?
|
Chlordiazepoxide | 1 | 2007 | 42 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2012 | 1982 | 0.020 |
Why?
|
Histones | 1 | 2017 | 2583 | 0.020 |
Why?
|
Cricetinae | 1 | 2010 | 2427 | 0.020 |
Why?
|
Antigens, CD | 1 | 2017 | 4000 | 0.020 |
Why?
|
Mood Disorders | 1 | 2013 | 1124 | 0.020 |
Why?
|
Receptors, Dopamine D2 | 1 | 2009 | 485 | 0.020 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 2006 | 143 | 0.020 |
Why?
|
Amphetamine | 1 | 2007 | 224 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 5785 | 0.020 |
Why?
|
Piperazines | 1 | 2016 | 2525 | 0.020 |
Why?
|
Mice, Neurologic Mutants | 1 | 2005 | 107 | 0.020 |
Why?
|
Receptors, AMPA | 1 | 2006 | 323 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9631 | 0.020 |
Why?
|
Genetic Variation | 1 | 2000 | 6551 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2001 | 3763 | 0.010 |
Why?
|
Bankruptcy | 1 | 2004 | 26 | 0.010 |
Why?
|
Pimozide | 1 | 2004 | 21 | 0.010 |
Why?
|
Patch-Clamp Techniques | 1 | 2006 | 932 | 0.010 |
Why?
|
Social Environment | 2 | 2000 | 1022 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2006 | 1095 | 0.010 |
Why?
|
Cotinine | 1 | 2004 | 203 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2803 | 0.010 |
Why?
|
Tetracycline | 1 | 2003 | 220 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7343 | 0.010 |
Why?
|
Dendrites | 1 | 2005 | 475 | 0.010 |
Why?
|
Pentylenetetrazole | 1 | 2002 | 71 | 0.010 |
Why?
|
Reward | 1 | 2009 | 963 | 0.010 |
Why?
|
Pyridinium Compounds | 1 | 2002 | 81 | 0.010 |
Why?
|
GABA Antagonists | 1 | 2002 | 120 | 0.010 |
Why?
|
Stress, Psychological | 1 | 1997 | 4446 | 0.010 |
Why?
|
3,4-Dihydroxyphenylacetic Acid | 1 | 2001 | 63 | 0.010 |
Why?
|
Cholinergic Fibers | 1 | 2001 | 69 | 0.010 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2002 | 202 | 0.010 |
Why?
|
Estrus | 1 | 2001 | 70 | 0.010 |
Why?
|
Prisoners | 1 | 2004 | 310 | 0.010 |
Why?
|
Presynaptic Terminals | 1 | 2003 | 301 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 16939 | 0.010 |
Why?
|
Clathrin | 1 | 2002 | 257 | 0.010 |
Why?
|
Transgenes | 1 | 2003 | 1006 | 0.010 |
Why?
|
Inflammation | 1 | 2019 | 10756 | 0.010 |
Why?
|
Blotting, Western | 1 | 2006 | 5039 | 0.010 |
Why?
|
Acetylcholine | 1 | 2001 | 629 | 0.010 |
Why?
|
Electrophysiology | 1 | 2001 | 1265 | 0.010 |
Why?
|
Gyrus Cinguli | 1 | 2005 | 1114 | 0.010 |
Why?
|
Age Distribution | 1 | 2004 | 2893 | 0.010 |
Why?
|
Aged | 3 | 2021 | 169152 | 0.010 |
Why?
|
Age of Onset | 1 | 2004 | 3301 | 0.010 |
Why?
|
Cell Division | 1 | 2004 | 4463 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2004 | 2659 | 0.010 |
Why?
|
Cell Survival | 1 | 2006 | 5797 | 0.010 |
Why?
|
Glutamic Acid | 1 | 2002 | 1167 | 0.010 |
Why?
|
Point Mutation | 1 | 2001 | 1594 | 0.010 |
Why?
|
Species Specificity | 1 | 2000 | 2418 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2006 | 2895 | 0.010 |
Why?
|
Calcium | 1 | 2009 | 5725 | 0.010 |
Why?
|
Phosphorylation | 1 | 2006 | 8313 | 0.010 |
Why?
|
Motivation | 1 | 2004 | 1993 | 0.010 |
Why?
|
Estrogens | 1 | 2001 | 1520 | 0.010 |
Why?
|
Opioid-Related Disorders | 1 | 2009 | 2138 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2002 | 1913 | 0.010 |
Why?
|
Alcoholism | 1 | 2004 | 1961 | 0.010 |
Why?
|
Extinction, Psychological | 1 | 1996 | 371 | 0.010 |
Why?
|
Naloxone | 1 | 1995 | 369 | 0.010 |
Why?
|
Models, Neurological | 1 | 2000 | 1758 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2003 | 3604 | 0.010 |
Why?
|
Adolescent | 2 | 2013 | 87810 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2005 | 12766 | 0.010 |
Why?
|
Apoptosis | 1 | 2004 | 9501 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2013 | 58995 | 0.000 |
Why?
|
Survival Rate | 1 | 2002 | 12808 | 0.000 |
Why?
|
Young Adult | 1 | 2013 | 58741 | 0.000 |
Why?
|
Middle Aged | 2 | 2013 | 220352 | 0.000 |
Why?
|
Adult | 2 | 2013 | 219994 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 2004 | 25942 | 0.000 |
Why?
|